Literature DB >> 15906947

Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.

Eun Hui Bae1, Sang Yup Lim, Myung Ho Jeong, Hyung Wook Park, Ji Hyun Lim, Young Joon Hong, Weon Kim, Ju Han Kim, Jeong Gwan Cho, Young Keun Ahn, Jong Chun Park, Soon Pal Suh, Byoung Hee Ahn, Sang Hyung Kim, Jung Chaee Kang.   

Abstract

BACKGROUND: Cardiogenic shock (CS) after acute myocardial infarction (AMI) develops in 5-10% of patients and it is associated with high mortality. The aim of this study is to assess the predictive factors of mortality for patients with AMI and CS.
METHODS: Two hundred fifty five AMI patients with CS (the mean age was 66.0 +/- 11.0 years, M:F=156:99) out of 1268 AMI patients who admitted at Chonnam National University Hospital between July 2000 and June 2002 were analyzed according to the clinical characteristics, coronary angiographic findings and MACE during admission and for the 1-year clinical follow-up.
RESULTS: Among the enrolled patients, 129 patients survived without MACE (Group I, mean age 64.2 +/- 10.6 years, M:F=76:53), and 126 patients had MACE (Group II, mean age 68.1 +/- 10.0 years, M:F = 80:46) during admission or during the 1-year follow-up period. There were significant differences in age between the Groups I and II (64.2 +/- 10.6 vs. 68.1 +/- 11.0 years, respectively, p = 0.004) and the previous MI history (0 vs. 17.4%, respectively, p<0.001). The left ventricular ejection fraction (EF) was lower in Group II (Group I vs. II: 49.1 +/- 13.0 vs. 39.1 +/- 12.9%, p < 0.001). The levels of troponin (Tn) I and C-reactive protein (CRP) were higher in Group II (Group I vs. II: 29.2 +/- 7.72 vs. 50.8 +/- 5.17 ng/dL, p = 0.017, 3.8 +/- 0.48 vs. 9.9 +/- 1.21 mg/dL, p < 0.001 respectively). Left main stem lesion (LMSL) was more common in Group II than in Group I (0.7% vs. 22.0%, respectively, p = 0.004). In-hospital death was associated with low Thrombolysis In Myocardial Infarction (TIMI) flow after coronary revascularization.
CONCLUSION: Old age, a previous MI history, high Tn and CRP, low EF and LMSL are associated with higher MACE for patients with AMI and CS. Coronary revascularization with TIMI 3 flow lowers the in-hospital mortality.

Entities:  

Mesh:

Year:  2005        PMID: 15906947      PMCID: PMC3891418          DOI: 10.3904/kjim.2005.20.1.8

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  26 in total

1.  Outcomes and early revascularization for patients > or = 65 years of age with cardiogenic shock.

Authors:  H L Dauerman; R J Goldberg; M Malinski; J Yarzebski; D Lessard; J M Gore
Journal:  Am J Cardiol       Date:  2001-04-01       Impact factor: 2.778

2.  Effect of early revascularization on mortality from cardiogenic shock complicating acute myocardial infarction in California.

Authors:  M E Edep; D L Brown
Journal:  Am J Cardiol       Date:  2000-05-15       Impact factor: 2.778

3.  Intra-aortic balloon counterpulsation: outcome in cardiac surgical patients.

Authors:  P Castelli; A Condemi; M Munari; C Savi; C Carro; P Vanelli
Journal:  J Cardiothorac Vasc Anesth       Date:  2001-12       Impact factor: 2.628

4.  Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry.

Authors:  J G Webb; T A Sanborn; L A Sleeper; R G Carere; C E Buller; J N Slater; K W Baran; P T Koller; J D Talley; M Porway; J S Hochman
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

5.  The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.

Authors:  H V Barron; N R Every; L S Parsons; B Angeja; R J Goldberg; J M Gore; T M Chou
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

6.  Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction.

Authors:  R J Goldberg; J M Gore; C A Thompson; J H Gurwitz
Journal:  Am Heart J       Date:  2001-01       Impact factor: 4.749

7.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

8.  Long-term results after acute percutaneous transluminal coronary angioplasty in acute myocardial infarction and cardiogenic shock.

Authors:  Peter Ammann; Edwin Straumann; Barbara Naegeli; Ernst Schuiki; Jürgen Frielingsdorf; Andreas Gerber; Osmund Bertel
Journal:  Int J Cardiol       Date:  2002-02       Impact factor: 4.164

9.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

10.  Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.

Authors: 
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

View more
  2 in total

1.  Combined Assessments of Biochemical Markers and ST-Segment Resolution Provide Additional Prognostic Information for Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Jong Shin Woo; Jin Man Cho; Soo Joong Kim; Myeong Kon Kim; Chong Jin Kim
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

2.  Roles of ST2, IL-33 and BNP in predicting major adverse cardiovascular events in acute myocardial infarction after percutaneous coronary intervention.

Authors:  Yan-Peng Wang; Jian-Hua Wang; Xiao-Long Wang; Jun-Yi Liu; Fang-Yun Jiang; Xiao-Li Huang; Jing-Yu Hang; Wei Qin; Shi-Xin Ma; Jie Zhang; Min-Jie Yuan; Jing-Bo Li; Zhi-Gang Lu; Meng Wei
Journal:  J Cell Mol Med       Date:  2017-06-17       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.